BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 15226334)

  • 1. Prognostic significance of molecular upstaging of paraffin-embedded sentinel lymph nodes in melanoma patients.
    Takeuchi H; Morton DL; Kuo C; Turner RR; Elashoff D; Elashoff R; Taback B; Fujimoto A; Hoon DS
    J Clin Oncol; 2004 Jul; 22(13):2671-80. PubMed ID: 15226334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular upstaging based on paraffin-embedded sentinel lymph nodes: ten-year follow-up confirms prognostic utility in melanoma patients.
    Nicholl MB; Elashoff D; Takeuchi H; Morton DL; Hoon DS
    Ann Surg; 2011 Jan; 253(1):116-22. PubMed ID: 21135695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of disease outcome in melanoma patients by molecular analysis of paraffin-embedded sentinel lymph nodes.
    Kuo CT; Hoon DS; Takeuchi H; Turner R; Wang HJ; Morton DL; Taback B
    J Clin Oncol; 2003 Oct; 21(19):3566-72. PubMed ID: 12913098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular staging of pathologically negative sentinel lymph nodes from melanoma patients using multimarker, quantitative real-time rt-PCR.
    Hilari JM; Mangas C; Xi L; Paradelo C; Ferrándiz C; Hughes SJ; Yueh C; Altomare I; Gooding WE; Godfrey TE
    Ann Surg Oncol; 2009 Jan; 16(1):177-85. PubMed ID: 18982394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of occult metastases detected by sentinel lymphadenectomy and reverse transcriptase-polymerase chain reaction in early-stage melanoma patients.
    Bostick PJ; Morton DL; Turner RR; Huynh KT; Wang HJ; Elashoff R; Essner R; Hoon DS
    J Clin Oncol; 1999 Oct; 17(10):3238-44. PubMed ID: 10506625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of molecular staging study of sentinel lymph nodes by reverse transcriptase-polymerase chain reaction for tyrosinase in melanoma patients.
    Mangas C; Hilari JM; Paradelo C; Rex J; Fernández-Figueras MT; Fraile M; Alastrue A; Ferrándiz C
    Ann Surg Oncol; 2006 Jul; 13(7):910-8. PubMed ID: 16788751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serial follow-up and the prognostic significance of reverse transcriptase-polymerase chain reaction--staged sentinel lymph nodes from melanoma patients.
    Kammula US; Ghossein R; Bhattacharya S; Coit DG
    J Clin Oncol; 2004 Oct; 22(19):3989-96. PubMed ID: 15459222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of occult melanoma cells in paraffin-embedded histologically negative sentinel lymph nodes using a reverse transcriptase polymerase chain reaction assay.
    Palmieri G; Ascierto PA; Cossu A; Mozzillo N; Motti ML; Satriano SM; Botti G; Caracò C; Celentano E; Satriano RA; Lissia A; Tanda F; Pirastu M; Castello G;
    J Clin Oncol; 2001 Mar; 19(5):1437-43. PubMed ID: 11230489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases.
    Vitoux D; Mourah S; Kerob D; Verola O; Basset-Seguin N; Baccard M; Schartz N; Ollivaud L; Archimbaud A; Servant JM; Revol M; Toubert ME; Podgorniak MP; Plassa F; Porcher R; Lebbé C
    Arch Dermatol; 2009 Oct; 145(10):1105-13. PubMed ID: 19841396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective multi-institutional study of reverse transcriptase polymerase chain reaction for molecular staging of melanoma.
    Scoggins CR; Ross MI; Reintgen DS; Noyes RD; Goydos JS; Beitsch PD; Urist MM; Ariyan S; Davidson BS; Sussman JJ; Edwards MJ; Martin RC; Lewis AM; Stromberg AJ; Conrad AJ; Hagendoorn L; Albrecht J; McMasters KM
    J Clin Oncol; 2006 Jun; 24(18):2849-57. PubMed ID: 16782924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic value of a reverse transcriptase-PCR assay of sentinel lymph node biopsy for patients with cutaneous melanoma: a single-center analysis in Japan.
    Ito T; Moroi Y; Oba J; Nakahara T; Takeuchi S; Uchi H; Takahara M; Masuda T; Furue M
    Melanoma Res; 2012 Feb; 22(1):38-44. PubMed ID: 22108607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Examination of regional lymph nodes by sentinel node biopsy and molecular analysis provides new staging facilities in primary cutaneous melanoma.
    Blaheta HJ; Ellwanger U; Schittek B; Sotlar K; MacZey E; Breuninger H; Thelen MH; Bueltmann B; Rassner G; Garbe C
    J Invest Dermatol; 2000 Apr; 114(4):637-42. PubMed ID: 10733666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular staging of the sentinel lymph node in melanoma patients: correlation with clinical outcome.
    Romanini A; Manca G; Pellegrino D; Murr R; Sarti S; Bianchi F; Alsharif A; Orlandini C; Zucchi V; Castagna M; Gandini D; Salimbeni G; Ghiara F; Barachini P; Mariani G
    Ann Oncol; 2005 Nov; 16(11):1832-40. PubMed ID: 16107497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of melanoma cells in the lymphatic drainage after lymph node dissection in melanoma patients by using two-marker reverse transcriptase-polymerase chain reaction assay.
    Włodzimierz R; Rutkowski P; Nowecki ZI; Kulik J; Nasierowska-Guttmejer A; Siedlecki JA
    Ann Surg Oncol; 2004 Nov; 11(11):988-97. PubMed ID: 15525828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Staging of Sentinel Lymph Nodes Identifies Melanoma Patients at Increased Risk of Nodal Recurrence.
    Kimbrough CW; Egger ME; McMasters KM; Stromberg AJ; Martin RC; Philips P; Scoggins CR
    J Am Coll Surg; 2016 Apr; 222(4):357-63. PubMed ID: 26875070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sentinel lymph node: detection of micrometastases of melanoma in a molecular study.
    Denninghoff VC; Kahn AG; Falco J; Curutchet HP; Elsner B
    Mol Diagn; 2004; 8(4):253-8. PubMed ID: 15887981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
    Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
    Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular staging of malignant melanoma: correlation with clinical outcome.
    Shivers SC; Wang X; Li W; Joseph E; Messina J; Glass LF; DeConti R; Cruse CW; Berman C; Fenske NA; Lyman GH; Reintgen DS
    JAMA; 1998 Oct; 280(16):1410-5. PubMed ID: 9801000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of micrometastasis in sentinel lymph nodes of patients with primary cutaneous melanoma.
    Blaheta HJ; Schittek B; Breuninger H; Garbe C
    Recent Results Cancer Res; 2001; 158():137-46. PubMed ID: 11092041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of melanoma cells in sentinel lymph nodes, bone marrow and peripheral blood by a reverse transcription-polymerase chain reaction assay in patients with primary cutaneous melanoma: association with Breslow's tumour thickness.
    Blaheta HJ; Paul T; Sotlar K; Maczey E; Schittek B; Paul A; Moehrle M; Breuninger H; Bueltmann B; Rassner G; Garbe C
    Br J Dermatol; 2001 Aug; 145(2):195-202. PubMed ID: 11531779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.